Page 3 - ராஜேஷ் ஜெயின் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ராஜேஷ் ஜெயின். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ராஜேஷ் ஜெயின் Today - Breaking & Trending Today

Sputnik V vaccine: Panacea Biotec's Baddi unit gets license from DCGI to manufacture jabs

Sputnik V vaccine: Panacea Biotec s Baddi unit gets license from DCGI to manufacture jabs
Moneycontrol
6 hours ago
Viswanath Pilla
© Sandip Das
Sputnik V vaccine: Panacea Biotec s Baddi unit gets license from DCGI to manufacture jabs
Panacea Biotec announced that it had received a license from the Drugs Controller General of India (DCGI) to manufacture Sputnik V vaccine against COVID-19 at its Baddi facility in Himachal Pradesh.
The license is a necessary condition for using Sputnik V produced by Panacea Biotec in India.
Panacea said the batches produced at Panacea Biotec’s facilities at Baddi, Himachal Pradesh were earlier shipped to the Gamaleya Center in Russia for quality control. ....

Himachal Pradesh , Biotec Baddi , Rajesh Jain , Central Drug Laboratory , Gamaleya Center , Russian Direct Investment Fund , Panacea Biotec , Drugs Controller General , Hon Ble Prime , Managing Director , இமாச்சல் பிரதேஷ் , ராஜேஷ் ஜெயின் , மைய மருந்து ஆய்வகம் , ரஷ்ய நேரடி முதலீடு நிதி , சஞ்சீவி பயோடெக் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , க .ரவ ப்ளே ப்ரைம் , நிர்வகித்தல் இயக்குனர் ,

Panacea Bio gets DCGI nod to make Sputnik V

Panacea Bio gets DCGI nod to make Sputnik V
sakshi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sakshi.com Daily Mail and Mail on Sunday newspapers.

Himachal Pradesh , New Delhi , Tamil Nadu , Rajesh Jain , Russian Direct The Fund , Russia National Center , Russian Direct , இமாச்சல் பிரதேஷ் , புதியது டெல்ஹி , தமிழ் நாடு , ராஜேஷ் ஜெயின் , ரஷ்யா தேசிய மையம் , ரஷ்ய நேரடி ,

Sputnik V India manufacturing update: Panacea Biotec gets DCGI nod to produce Russia's COVID-19 vaccine- check ADVANTAGES of the vaccine here

Sputnik V India manufacturing update: Panacea Biotec gets DCGI nod to produce Russia s COVID-19 vaccine- check ADVANTAGES of the vaccine here
[email protected] (Zee Business)
© Provided by Zee Business
Panacea Biotec Latest News: The Drug Controller General of India (DCGI) has approved biotechnology company Panacea Biotech to manufacture Russia s COVID-19 vaccine Sputnik V in India.
Panacea Biotec has also issued a press release in this regard. The biotechnology company has received the license to produce Sputnik V at Baddi, Himachal Pradesh.
See Zee Business Live TV Streaming Below:
It must be noted that Sputnik V was registered in India under the emergency use authorisation procedure in April 12, 2021 and vaccination against COVID-19 with Sputnik V started on May 14, 2021. The Russian Sputnik V COVID-19 vaccine has been registered in 67 countries with total population of over 3.5 billion. ....

Himachal Pradesh , Rajesh Jain , Central Drug Laboratory , Gamaleya Center , Biotec Latest News , Drug Controller General , Panacea Biotech , Panacea Biotec , Managing Director , Prime Minister , இமாச்சல் பிரதேஷ் , ராஜேஷ் ஜெயின் , மைய மருந்து ஆய்வகம் , மருந்து கட்டுப்படுத்தி ஜநரல் , சஞ்சீவி பயோடெக் , நிர்வகித்தல் இயக்குனர் , ப்ரைம் அமைச்சர் ,

Panacea Biotec soars on receiving license to make Sputnik V vaccine

Panacea Biotec surges 6.77% to Rs 402.95 after the company said it received manufacturing license from Drug Controller General (India) for Sputnik V vaccine against Covid-19.
The license is a necessary condition for using Sputnik V produced by Panacea Biotec in India. The batches produced at Panacea Biotec s facilities at Baddi, Himachal Pradesh were earlier shipped to the Gamaleya Center in Russia for quality control. The batches have passed all the checks for quality parameters both at the Gamaleya Center in Russia and at the Central Drug Laboratory, Kasauli, Himachal Pradesh in India.
Sputnik V was registered in India under the emergency use authorization procedure on 12 April 2021 and vaccination against COVID-19 with the Russian vaccine started on 14 May 2021. Sputnik V has been registered in 67 countries globally with total population of over 3.5 billion people. The vaccine is based on a proven and well-studied platform of human adenoviral vectors and uses two diffe ....

Himachal Pradesh , Rajesh Jain , Central Drug Laboratory , Gamaleya Center , Panacea Biotec , Drug Controller General , Hon Ble Prime Minister Modi , Capital Market , இமாச்சல் பிரதேஷ் , ராஜேஷ் ஜெயின் , மைய மருந்து ஆய்வகம் , சஞ்சீவி பயோடெக் , மருந்து கட்டுப்படுத்தி ஜநரல் , க .ரவ ப்ளே ப்ரைம் அமைச்சர் மோடி , மூலதனம் சந்தை ,

Panacea Bio receives license from DCGI to produce Sputnik V vaccine

Panacea Bio receives license from DCGI to produce Sputnik V vaccine
india.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from india.com Daily Mail and Mail on Sunday newspapers.

Himachal Pradesh , New Delhi , Narendra Modi , Rajesh Jain , Gamaleya Center , Russian Direct Investment Fund , Drugs Controller General , Panacea Biotec , Russian Direct Investment , Managing Director , Prime Minister Narendra Modi , இமாச்சல் பிரதேஷ் , புதியது டெல்ஹி , நரேந்திர மோடி , ராஜேஷ் ஜெயின் , ரஷ்ய நேரடி முதலீடு நிதி , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , சஞ்சீவி பயோடெக் , ரஷ்ய நேரடி முதலீடு , நிர்வகித்தல் இயக்குனர் , ப்ரைம் அமைச்சர் நரேந்திர மோடி ,